医学
病毒学
流感减毒活疫苗
流感疫苗
信使核糖核酸
病毒
基因
遗传学
生物
出处
期刊:JAMA
[American Medical Association]
日期:2021-11-09
卷期号:326 (18): 1784-1784
被引量:4
标识
DOI:10.1001/jama.2021.19634
摘要
Following close on the heels of Moderna Inc, pharmaceutical giant Pfizer announced a phase 1 trial of mRNA-based influenza vaccine candidates. The program will start with candidates encoding individual influenza virus strains, leading up to tests of multivalent combinations.
科研通智能强力驱动
Strongly Powered by AbleSci AI